Department of Epidemiology and Health Statistics, The College of Public Health of Qingdao University, Qingdao, Shandong, People's Republic of China.
J Hypertens. 2019 Dec;37(12):2371-2379. doi: 10.1097/HJH.0000000000002200.
Few epidemiological studies concentrated on dietary carotenoids and hypertension since new hypertension guideline released in 2017. Thus, this study was aimed to evaluate their association.
Data from National Health and Nutrition Examination Survey (NHANES) 2007-2014 were used in this cross-sectional study. Dietary carotenoids data were obtained from 24-h dietary recall interviews. Hypertension was defined as SBP at least 130 mmHg or DBP at least 80 mmHg, taking antihypertensive medicine or self-report. Logistic regression models and restricted cubic spline models were applied to explore the associations between α-carotene, β-carotene, β-cryptoxanthin, lycopene, lutein with zeaxanthin, and total carotenoids from diet and supplements and hypertension. Total carotenoids showed significant reductive risk of hypertension at 100 μg/kg per day and over.
A total of 17 398 adults aged 20 years and over were identified. High dose of β-carotene, lycopene, lutein with zeaxanthin, and total carotenoids were significantly associated with decreased risk of hypertension in crude results. After multivariate-adjustment in model 2, the odds ratios (OR) with 95% confidence intervals (CI) of β-cryptoxanthin, lycopene, lutein with zeaxanthin and total carotenoids for hypertension were 0.79 (0.67-0.93), 0.85 (0.73-0.98), 0.69 (0.58-0.83), 0.73 (0.62-0.86) for the highest versus lowest quartile intakes, respectively. Dose-response analyses showed that all of the carotenoids were inversely associated with hypertension in a linear manner. Total carotenoids showed significant effect of lower risk of hypertension at 100 μg/kg per day.
Intakes of α-carotene, β-carotene, β-cryptoxanthin, lycopene, lutein with zeaxanthin, and total carotenoids were inversely associated with hypertension in US adults. The intake of total carotenoids was suggested at least 100 μg/kg per day for general adult population.
自 2017 年发布新的高血压指南以来,很少有流行病学研究集中在膳食类胡萝卜素与高血压之间的关系上。因此,本研究旨在评估它们之间的关联。
本横断面研究使用了 2007-2014 年全国健康和营养调查(NHANES)的数据。膳食类胡萝卜素数据来自 24 小时膳食回忆访谈。高血压定义为收缩压至少 130mmHg 或舒张压至少 80mmHg,服用降压药或自我报告。应用逻辑回归模型和限制三次样条模型探讨饮食和补充剂中 α-胡萝卜素、β-胡萝卜素、β-隐黄质、番茄红素、叶黄素和玉米黄质与高血压之间的关系。结果显示,膳食总类胡萝卜素摄入量达到 100μg/kg/天时,高血压的发生风险呈显著降低趋势。
共纳入 17398 名 20 岁及以上成年人。β-胡萝卜素、番茄红素、叶黄素和玉米黄质的高剂量与高血压的发生风险呈显著负相关。在模型 2 中进行多变量调整后,β-隐黄质、番茄红素、叶黄素和玉米黄质与高血压的比值比(OR)及其 95%置信区间(CI)分别为 0.79(0.67-0.93)、0.85(0.73-0.98)、0.69(0.58-0.83)和 0.73(0.62-0.86)。剂量反应分析表明,所有类胡萝卜素与高血压呈线性负相关。膳食总类胡萝卜素摄入量达到 100μg/kg/天时,高血压的发生风险显著降低。
美国成年人膳食类胡萝卜素摄入量与高血压呈负相关。建议一般成年人群的总类胡萝卜素摄入量至少为 100μg/kg/天。